U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CVM GFI #115 (VICH GL22) Safety Studies for Veterinary Drug Residues in Human Food: Reproduction Toxicity Testing
  1. Regulatory Information

GUIDANCE DOCUMENT

CVM GFI #115 (VICH GL22) Safety Studies for Veterinary Drug Residues in Human Food: Reproduction Toxicity Testing July 2006

Final

CVM GFI #115 (VICH GL22) Safety Studies for Veterinary Drug Residues in Human Food: Reproduction Toxicity Testing

Docket Number:
FDA-2000-D-0784
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine

In order to establish the safety of veterinary drug residues in human food, a number of toxicological evaluations are recommended, including the assessment of any risks to reproduction. The objective of this guidance is to ensure international harmonization of reproduction toxicity testing, which is appropriate for the evaluation of risks to reproduction from long-term, low-dose exposures, such as may be encountered from the presence of veterinary drug residues in food.

The current guidance is one of a series of guidances developed to facilitate the mutual acceptance of safety data necessary for the determination of Acceptable Daily Intakes (ADIs) for veterinary drug residues in human food by the relevant regulatory authorities. This guidance should be read in conjunction with the guidance on the overall strategy for the safety evaluation of veterinary residues in human food (see VICH GL-33).

This document provides guidance on the core recommendation for a multigeneration study for those veterinary medicinal products that leave residues in human food.  However, it does not seek to limit the studies that may be performed to establish the safety of residues in human food with respect to reproductive function. Neither does it preclude the possibility of alternative approaches that may offer an equivalent assurance of safety, including scientifically-based reasons as to why such data may not need to be provided. This guidance is not intended to cover the information that may be recommended to establish the safety of a veterinary product with respect to reproduction in the target species.


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2000-D-0784.

Questions?

Contact Point
CVM
Center for Veterinary Medicine
Food and Drug Administration
7500 Standish Pl, HFV-1
Rockville, MD 20855
AskCVM@fda.hhs.gov
(240) 402-7002